| scholarly article | Q13442814 |
| P50 | author | Mats Bemark | Q43086313 |
| Nils Y. Lycke | Q76735921 | ||
| P2093 | author name string | Anna Holmberg | |
| Johan Mattsson | |||
| Anneli Stensson | |||
| Peter Bergqvist | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholera | Q12090 |
| memory B cell | Q1195394 | ||
| P304 | page(s) | 1399-1410 | |
| P577 | publication date | 2011-01-03 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | A unique role of the cholera toxin A1-DD adjuvant for long-term plasma and memory B cell development | |
| P478 | volume | 186 |
| Q36711264 | A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing |
| Q40106084 | Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation |
| Q39015429 | As a genetic adjuvant, CTA improves the immunogenicity of DNA vaccines in an ADP-ribosyltransferase activity- and IL-6-dependent manner. |
| Q59349637 | Basics of memory B-cell responses: lessons from and for the real world |
| Q38659933 | CD73 expression identifies a subset of IgM+ antigen-experienced cells with memory attributes that is T cell and CD40 signalling dependent. |
| Q33928841 | CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype. |
| Q37977139 | Induction of gut IgA production through T cell-dependent and T cell-independent pathways |
| Q59359566 | Intranasal inoculate of influenza virus vaccine against lethal virus challenge |
| Q50737014 | Long-lived plasma cells are generated in mucosal immune responses and contribute to the bone marrow plasma cell pool in mice. |
| Q30370790 | Long-term immunogenicity of an inactivated split-virion 2009 pandemic influenza A H1N1 virus vaccine with or without aluminum adjuvant in mice |
| Q40291797 | M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection. |
| Q37833985 | Multistage vaccines containing outer membrane, type III secretion system and inclusion membrane proteins protects against a Chlamydia genital tract infection and pathology |
| Q84564316 | Re-utilization of germinal centers in multiple Peyer's patches results in highly synchronized, oligoclonal, and affinity-matured gut IgA responses |
| Q38029250 | Recent progress in mucosal vaccine development: potential and limitations |
| Q26777264 | Roles and relevance of mast cells in infection and vaccination |
| Q50928936 | Single immunization with a suboptimal antigen dose encapsulated into polyanhydride microparticles promotes high titer and avid antibody responses. |
| Q35685300 | Strategies to guide the antibody affinity maturation process |
| Q92783587 | The CTA1-DD adjuvant strongly potentiates follicular dendritic cell function and germinal center formation, which results in improved neonatal immunization |
| Q39168847 | The immune complex CTA1-DD/IgG adjuvant specifically targets connective tissue mast cells through FcγRIIIA and augments anti-HPV immunity after nasal immunization |
| Q27312551 | The longevity of Th2 humoral response induced by proteases natterins requires the participation of long-lasting innate-like B cells and plasma cells in spleen |
| Q42155365 | The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model |
| Q39459081 | The regulation of gut mucosal IgA B-cell responses: recent developments |
| Q38062531 | The role of Peyer's patches in synchronizing gut IgA responses |
| Q37963475 | Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes |
| Q34706875 | Uncoupling of natural IgE production and CD23 surface expression levels |
| Q90929866 | ZBTB32 restrains antibody responses to murine cytomegalovirus infections, but not other repetitive challenges |
Search more.